Matrix Capital Management — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
BiotechSouth San Francisco, US
Stephanie Tagliatela(Co-founder, Chief Scientific Officer & Board Member)inKartik Ramamoorthi, Ph.D.(Co-founder, Chief Executive Officer & Board Member)
Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision Fund+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Predible Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




